Medicon Hellas S.A. (MEDIC) - Total Assets
Based on the latest financial reports, Medicon Hellas S.A. (MEDIC) holds total assets worth €31.81 Million EUR (≈ $37.19 Million USD) as of December 2022. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See MEDIC book value for net asset value and shareholders' equity analysis.
Medicon Hellas S.A. - Total Assets Trend (2014–2022)
This chart illustrates how Medicon Hellas S.A.'s total assets have evolved over time, based on quarterly financial data.
Medicon Hellas S.A. - Asset Composition Analysis
Current Asset Composition (December 2022)
Medicon Hellas S.A.'s total assets of €31.81 Million consist of 0.0% current assets and 0.0% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €10.21 Million | 0.0% |
| Accounts Receivable | €8.26 Million | 26.0% |
| Inventory | €2.77 Million | 8.7% |
| Property, Plant & Equipment | €6.69 Million | 21.1% |
| Intangible Assets | €55.86K | 0.2% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2014–2022)
This chart illustrates how Medicon Hellas S.A.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see MEDIC market cap overview.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Medicon Hellas S.A.'s current assets represent 0.0% of total assets in 2022, a decrease from 58.0% in 2014.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2022, down from 11.0% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2014.
- Asset Diversification: The largest asset category is cash and equivalents at 0.0% of total assets.
Medicon Hellas S.A. Competitors by Total Assets
Key competitors of Medicon Hellas S.A. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Lavipharm S.A
AT:LAVI
|
Greece | €125.48 Million |
|
Trastor Real Estate Investment Company SA
AT:TRASTOR
|
Greece | €867.78 Million |
|
Dimand S.A.
AT:DIMAND
|
Greece | €365.77 Million |
|
Alumil Aluminium Industry S.A
AT:ALMY
|
Greece | €516.26 Million |
|
Eurobank Ergasias Services and Holdings S.A.
AT:EUROB
|
Greece | €102.98 Billion |
|
National Bank of Greece S.A
AT:ETE
|
Greece | €76.73 Billion |
|
Alpha Services and Holdings S.A.
AT:ALPHA
|
Greece | €73.48 Billion |
|
Piraeus Financial Holdings S.A
AT:TPEIR
|
Greece | €81.25 Billion |
Medicon Hellas S.A. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.32 | 4.75 | 2.24 |
| Quick Ratio | 4.60 | 4.18 | 1.90 |
| Cash Ratio | 0.00 | 2.12 | 0.00 |
| Working Capital | €18.56 Million | €18.05 Million | €10.23 Million |
Medicon Hellas S.A. - Advanced Valuation Insights
This section examines the relationship between Medicon Hellas S.A.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.36 |
| Asset Growth Rate (YoY) | 2.0% |
| Total Assets | €31.81 Million |
| Market Capitalization | $11.31 Million USD |
Valuation Analysis
Below Book Valuation: The market values Medicon Hellas S.A.'s assets below their book value (0.36x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Medicon Hellas S.A.'s assets grew by 2.0% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Medicon Hellas S.A. (2014–2022)
The table below shows the annual total assets of Medicon Hellas S.A. from 2014 to 2022.
| Year | Total Assets | Change |
|---|---|---|
| 2022-12-31 | €31.81 Million ≈ $37.19 Million |
+1.97% |
| 2021-12-31 | €31.19 Million ≈ $36.47 Million |
+9.03% |
| 2020-12-31 | €28.61 Million ≈ $33.45 Million |
+0.29% |
| 2019-12-31 | €28.53 Million ≈ $33.35 Million |
+4.82% |
| 2018-12-31 | €27.21 Million ≈ $31.82 Million |
-11.24% |
| 2017-12-31 | €30.66 Million ≈ $35.84 Million |
-7.14% |
| 2016-12-31 | €33.02 Million ≈ $38.60 Million |
+6.43% |
| 2015-12-31 | €31.02 Million ≈ $36.27 Million |
+8.08% |
| 2014-12-31 | €28.71 Million ≈ $33.56 Million |
-- |
About Medicon Hellas S.A.
Medicon Hellas S.A. operates in the diagnostics industry. The company offers instruments, tests, and procedures for public and private hospitals, primary care centers, diagnostic centers, and private laboratories in Greece and internationally. The company distributes various analyzer sysytem for chemistry, immunochemistry and hematology labs, intensive care units, and point-of-care systems. It al… Read more